The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance by the U.S. Food and Drug Administration.
Most Americans want to know if they’re destined to lose their brain power to Alzheimer’s disease, according to an annual report produced by the Alzheimer’s Association.
